Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis
A empresa admite no ter registro na Anvisa, mas afirma ser original e at possui um tira-dvidas no site para diferenciar as canetas originais das falsas
The active molecule is the same
Similarly, Wegovy is FDA-approved to reduce the risk of major cardiovascular events, such as heart attacks and strokes, in adults with known heart disease and obesity
Men face a much higher risk than women This does not, however, fully explain why a drug that is broadly beneficial for heart health and blood sugar control might have such a specific harmful effect on eyesight
Meanwhile, Lilly is also positioning Zepbound as an answer to obstructive sleep apnea, with an FDA decision expected as early as the end of the year